Mbizvo M T
Department of Obstetrics and Gynaecology, University of Zimbabwe, Harare.
Int J Androl. 1995 Jun;18 Suppl 1:1-6. doi: 10.1111/j.1365-2605.1995.tb00630.x.
Continued research to define the parameters of sperm function should aid the evaluation of various approaches in infertility as well as the efficacy of contraceptives for men which do not necessarily achieve azoospermia. Many treatment forms have been advocated for male factor infertility but have yielded little effect. These included, for example, gonadotrophins, clomiphene citrate, the weakly androgenic steroid, mesterolone. Often, improvements in oligoasthenozoospermia that are not related to genital infection, do not attain normozoospermic levels. Owing to lack of success with various treatment modalities, assisted reproductive technology encompassing artificial insemination by husband or donor following in vitro enhancement of sperm function have assumed an important role in male infertility. Agents that have been shown to induce and support sperm capacitation processes such as hyperactivation, could serve an important role. These include human follicular fluid (HFF), maternal serum, fetal cord serum and methyl xanthine derivatives.
持续开展研究以明确精子功能参数,应有助于评估治疗不育症的各种方法以及男性避孕药的功效,这些避孕药不一定会导致无精子症。针对男性因素不育症,人们提倡了多种治疗方式,但收效甚微。例如,这些治疗方式包括促性腺激素、枸橼酸氯米芬、弱雄激素类固醇美睾酮。通常,与生殖器感染无关的少弱精子症的改善情况,并未达到正常精子水平。由于各种治疗方式均未取得成功,包括在体外增强精子功能后由丈夫或供体进行人工授精的辅助生殖技术,在男性不育症治疗中发挥了重要作用。已证明能够诱导和支持精子获能过程(如超激活)的物质,可能会发挥重要作用。这些物质包括人卵泡液(HFF)、母体血清、胎儿脐带血清和甲基黄嘌呤衍生物。